Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,059,201
+$523,686 QoQ
Shares Held
2,925
+92.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,666
of 3,139 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Asset Management, LLC holds $14,808,473 across 9 Drug Manufacturers - General names. AMGN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,661 | $5,590,543 | |
| 2 | JNJ |
Johnson & Johnson
|
8,572 | $2,177,030 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,535 | $1,996,247 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
13,735 | $1,735,279 | |
| 5 | ABBV |
AbbVie Inc.
|
5,575 | $1,402,893 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,925 | $1,059,201 | |
| 7 | PFE |
Pfizer Inc
|
13,097 | $315,375 | |
| 8 | GSK |
GSK plc
|
5,455 | $285,951 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,059,201 | 2,925 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $535,515 | 1,522 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $355,458 | 1,086 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $306,187 | 1,085 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,193,064 | 4,273 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $343,016 | 1,101 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $300,058 | 7,040 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,251,463 | 3,884 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,226,678 | 3,926 | Shares | Sole | 2024-08-12 | |
| 2023-06-30 | $641,415 | 2,889 | Shares | Sole | 2023-08-01 | |
| No filing history on record for this holder in this stock. | ||||||